Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Interventional Agents Safety and Pharmacokinetic Services (IASPS)

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Interventional Agents Safety and Pharmacokinetic Services contract is a forecast opportunity issued by the National Institutes of Health. This initiative focuses on providing specialized safety and pharmacokinetic services related to interventional agents, falling under NAICS code 541714 for research and development in biotechnology. The program is managed by the National Institutes of Health, with Jeremy Starr serving as the Program Point of Contact and Miranda Adams acting as the Contracting Officer. Interested parties can find further details regarding this opportunity through the HHS Office of Strategic Business Units industry forecast portal.

General Info

NIH forecast for interventional agents safety and pharmacokinetic biotechnology research and development services.

Agency

National Institutes of Health → National Institutes Of Health

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyNational Institutes of Health → National Institutes Of Health

Contacts2 people available

OfficeN/A

Organization / AgencyNational Institutes of Health → National Institutes Of Health

Office AddressN/A

Contacts

Jeremy Starr

contact@example.gov

Miranda AdamsContracting Officer

contact@example.gov

Full Description

Show more

Interventional Agents Safety and Pharmacokinetic Services (IASPS)

Similar Contracts

Same NAICS industry code

Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)

Solicitation # RFA-AI-28-014

The National Institutes of Health (NIH) issued solicitation RFA-AI-28-014 to establish centers focused on the systems-level understanding of the links between infectious pathogens, inflammatory pathways, and chronic diseases. The program supports two types of centers: Chronic and Infectious Diseases Systems Biology Centers (CIDSB), which examine the bidirectional link between chronic and infectious diseases, and Systems Biology Inflammation Centers (SBI), which focus on the role of inflammation in chronic diseases to identify precision medicine targets. The primary goals are to develop predictive computational models for disease progression, discover novel drug targets and biomarkers, and create harmonized, FAIR-compliant cross-disease datasets. The total program funding is 26 million dollars, with an expected 10 awards and an individual award ceiling of 2.5 million dollars. Applications must be submitted electronically via Grants.gov by February 18, 2027. The proposal structure is multi-component, requiring an overall section, an administrative core, a data and modeling core, and a biospecimen collection and processing core, with additional requirements for research projects and optional cores depending on the center type. Evaluation is based on an overall impact score focusing on significance and the qualifications of the investigators. Awardees must comply with strict cybersecurity incident reporting requirements, notifying the HHS awarding agency within 48 hours of discovery, and must adhere to rigorous biosafety and human subjects protection standards. Applicants must maintain active SAM registration and UEI identifiers to be eligible for funding.

National Institutes Of Health

POSTED

about 19 hours ago

DEADLINE

In Vivo Efficacy and Toxicology StudiesThis subcontract, titled In Vivo Efficacy and Toxicology Studies, supports the National Institutes of Health and the Department of Health and Human Services by providing preclinical validation of biologic therapies for prime contractors on NIH/NINDS ADRD projects. The scope of work involves executing in vivo efficacy, safety pharmacology, and toxicology studies utilizing translationally appropriate animal models specifically for Alzheimer's and Frontotemporal Dementia. To fulfill the requirements, the contractor must utilize GLP-compliant toxicology lab facilities to ensure regulatory standards are met. The primary deliverables include comprehensive preclinical validation reports and detailed toxicology data packages necessary for Investigational New Drug submission. The project is categorized under NAICS code 541714, with a response deadline set for October 10, 2028.

National Institutes Of Health

POSTED

DEADLINE

in almost 2 years

Genome Editing Construct and Delivery System OptimizationThis subcontract focuses on the design and optimization of genome editing constructs and biologic delivery systems to support prime contractors on NIH/NINDS genomic therapy projects. The scope of work involves utilizing CRISPR/Cas technology along with viral and non-viral vectors to refine editing constructs and delivery mechanisms. The selected provider will be responsible for assessing critical metrics including bioactivity, target engagement, durability, pharmacokinetics, and bioavailability. The final deliverables for this engagement consist of optimized therapeutic leads accompanied by comprehensive bioactivity and pharmacokinetics data reports.

National Institutes Of Health

POSTED

DEADLINE

in almost 2 years

NCI Research Specialist (Clinician Scientist)The NCI Research Specialist subcontract involves providing leadership and implementation services for National Cancer Institute funded clinical trials on behalf of prime contractors. The selected clinician scientist will be responsible for writing and revising protocols for national cancer clinical trials, managing trials within a clinical trials office, and recruiting patients. Additionally, the role requires active participation in NCI scientific review, monitoring, and steering committees. Candidates must possess clinician scientist status and demonstrated experience in cancer clinical research. The contract requires a dedicated effort ranging from 2.4 to 4.8 person-months per year. This opportunity is associated with the National Institutes of Health under the Department of Health and Human Services, with a response deadline set for February 20, 2029.

National Institutes Of Health

POSTED

DEADLINE

in over 2 years

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Solicitation # RFA-NS-28-012

The National Institutes of Health, under the Department of Health and Human Services, has issued solicitation RFA-NS-28-012 to support the translation of genome editing and biologic therapies for Alzheimer's Disease-Related Dementias (ADRD). This includes Frontotemporal Dementia, Lewy Body Dementias, Vascular Contributions to Cognitive Impairment and Dementia, and Multiple Etiology Dementias. The program funds the entire translational pipeline, from therapeutic lead optimization and drug product development to IND-enabling studies and early first-in-human clinical evaluations. Key activities include optimizing editing constructs and delivery systems, demonstrating in vivo efficacy, conducting safety pharmacology and toxicology studies, and developing scalable manufacturing processes that align with regulatory expectations. The agency intends to commit 6 million dollars in both fiscal years 2028 and 2029, with an expected three awards and a maximum project period of five years. Individual annual budget caps are set at 1.3 million dollars in direct costs, increasing to 2.5 million dollars for projects involving clinical trials. Awards are governed by the Public Health Service Act and federal regulations 42 CFR Part 52 and 2 CFR Part 200. Evaluation is based on an Overall Impact Score considering significance, innovation, approach, investigator expertise, and environment, with a specific focus on the Target Product Profile and the use of quantitative Go/No-Go milestones. Eligible applicants include small businesses and other for-profit organizations. Requirements for submission include active registration in the System for Award Management, a Unique Entity Identifier, and eRA Commons accounts. Awardees must adhere to strict cybersecurity incident reporting protocols, notifying the agency within 48 hours of discovery, and must register applicable clinical trials with ClinicalTrials.gov. The solicitation features multiple application cycles with deadlines extending through October 10, 2028, and earliest start dates ranging from December 2027 to July 2029.

National Institutes Of Health

POSTED

DEADLINE

in almost 2 years

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Solicitation # PAR-28-042

Solicitation PAR-28-042, issued by the National Institutes of Health under the Department of Health and Human Services, is a funding opportunity designed to support the analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer. The program focuses on tools for cancer detection, diagnosis, prognosis, monitoring, and the prediction of treatment response or toxicity. Funding is available through either a phased UH2/UH3 mechanism or a standalone UH3 mechanism to facilitate laboratory optimization and clinical validation using human samples. Key deliverables include the demonstration of assay results associated with clinical endpoints, the establishment of statistical cut-off values, and the definition of sensitivity and specificity. All clinical laboratories must adhere to CLIA, GLP, or ISO 17025 standards. Awards are determined via a peer review system based on an overall impact score, evaluating the importance of the research, rigor and feasibility of the approach, and the expertise of the investigators and their environment. Specific evaluation criteria include the clarity of milestones for transitioning from UH2 to UH3 phases and the adequacy of commercialization plans. Eligible applicants include small businesses, for-profit organizations, higher education institutions, and 501(c)(3) nonprofits. Applicants must maintain active registrations in SAM.gov, eRA Commons, and Grants.gov. Additionally, recipients must comply with strict cybersecurity incident reporting requirements, notifying the agency within 48 hours of discovery, and ensure all human subject protocols are reviewed by an Institutional Review Board or Independent Ethics Committee.

National Institutes Of Health

POSTED

DEADLINE

in about 3 years

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Solicitation # PAR-28-042

The National Cancer Institute, under the National Institutes of Health, has issued solicitation PAR-28-042 to provide funding for the analytical and clinical validation of biomarkers and assays related to cancer. This initiative focuses on molecular, cellular, and imaging markers used for detection, diagnosis, prognosis, treatment response, prevention, and toxicity monitoring. The goal is to support laboratory optimization and validation for assays using human samples that address specific clinical needs and intended uses. Eligible projects may utilize either a standalone UH3 mechanism or a phased UH2/UH3 approach, though clinical trials are explicitly not allowed. The solicitation was posted on November 3, 2026, with a response deadline set for November 17, 2029.

National Cancer Institute

POSTED

DEADLINE

in about 3 years

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Solicitation # RFA-NS-28-012

The National Institute of Neurological Disorders and Stroke, under the National Institutes of Health, has issued solicitation RFA-NS-28-012 to support the translation of genome editing and biologic therapies for Alzheimer's Disease-Related Dementias. This initiative covers a broad range of conditions, including Frontotemporal Dementia, Lewy Body Dementias, Vascular Contributions to Cognitive Impairment and Dementia, and Multiple Etiology Dementias. The program is designed to advance the translational pipeline from initial therapeutic lead optimization and drug product development through IND-enabling studies and early clinical evaluation. Eligible activities include the optimization of delivery systems and editing constructs, the assessment of bioactivity and pharmacokinetics, and the demonstration of in vivo efficacy. Additionally, the funding supports safety pharmacology, toxicology studies, and the creation of scalable manufacturing processes and quality attributes that meet regulatory standards. This solicitation was posted on November 3, 2026, with a response deadline of October 11, 2028.

National Institute Of Neurological Disorders And Stroke

POSTED

DEADLINE

in almost 2 years

Insect Taxonomy and Identification SpecialistThis subcontract opportunity is for an Insect Taxonomy and Identification Specialist to support prime contractors on USDA Forest Health Protection projects through the Northern Research Station. The selected specialist will perform professional taxonomic screening and identification of raw insect trap samples, specifically focusing on species-level identification of wood-boring beetles and wood wasps, as well as identifying Coleoptera and select Hemiptera to the lowest taxonomic level. The work requires the use of taxonomic keys and high-powered microscopy, with final identification reports delivered in Word or PDF format. The solicitation was posted on November 2, 2026, with a response deadline of December 3, 2026. Classified under NAICS code 541714, the performance of this contract is associated with zip code 26505. Interested parties can find further details via the provided government workspace link.

Northern Research Station

POSTED

DEADLINE

Sanger and High-Throughput DNA Sequencing ServicesThis subcontract for the National Institutes of Health Olao involves providing Sanger and high-throughput DNA sequencing services for prime contractors on NIH/NIEHS projects. The scope of work includes executing whole-plasmid sequencing on yeast colonies, plasmid DNA, and PCR-generated samples derived from recombinant, human, and rodent DNA sources. To ensure precision, the contractor must utilize automated DNA sequencers and PCR thermocyclers equipped with electronic barcode tracking, while maintaining Phred-equivalent quality scores greater than 20 and delivering secure data files. The project is categorized under NAICS code 541714 and will be performed in Durham, North Carolina. Interested parties should note the response deadline of November 12, 2026, for this specialized genomic services requirement.

National Institutes Of Health Olao

POSTED

DEADLINE

DNA Sequencing Service

Solicitation # PCA-NIEHS-00080

The National Institutes of Health, through the National Institute of Environmental Health Sciences, is issuing a Small Business Sources Sought notice for solicitation PCA-NIEHS-00080 to identify capable providers for an indefinite-delivery indefinite-quantity contract. The requirement is for DNA sequencing services and associated bioinformatics support, primarily utilizing Sanger sequencing with a smaller volume of high-throughput whole-plasmid sequencing. The estimated workload is between 2,000 and 3,000 samples per month, including yeast colonies, plasmid DNA, and PCR-generated samples from human and rodent species. The intended period of performance is five years from the date of award, with a potential six-month extension per FAR 52.217-8. The selected contractor must provide a web-based ordering and tracking system, all necessary sample collection and shipping materials, and a reliable transportation method for samples from the NIEHS campus in Research Triangle Park, North Carolina. Key technical requirements include maintaining a Phred-equivalent quality score greater than 20 for sequencing and ensuring successful PCR amplification produces a single DNA band of the expected size. The contractor is responsible for preserving remaining DNA for at least 180 days and returning unused primers to the government. Administrative requirements include submitting invoices within ten business days of the billing cycle and maintaining strict confidentiality of all sequencing data. This notice is specifically targeting small business concerns, including 8(a), SDB, WOSB, HUBZone, VOSB, and SDVOSB designations. Interested parties must submit a capability statement of no more than seven pages, including their UEI, TIN, and business size certification, to Luz Casey by November 12, 2026.

National Institutes Of Health Olao

POSTED

DEADLINE

USDA SBIR/STTR Topic 8.2 — Plant Production and Protection - Biology

Solicitation # USDA-NIFA-TOPIC-8.2

The USDA National Institute of Food and Agriculture is soliciting proposals under Topic 8.2 for Plant Production and Protection - Biology. This initiative focuses on advancing crop production and protection through the development of innovative plant breeding methods, diagnostic technologies for diseases, and the creation of new food and non-food crop plants. Research efforts are directed toward improving plant characteristics to mitigate biotic and abiotic stresses, developing new genotypes for commercial applications, and creating tools to support the health of natural and domesticated pollinators. This opportunity is a total small business set-aside under the SBIR/STTR mandate, restricting eligibility to companies with fewer than 500 employees. Managed by the United States Department of Agriculture, the program is led by Dr. Christopher Philips. Interested parties can find further details and application guidelines through the NIFA website.

National Institute of Food and Agriculture

POSTED

DEADLINE

More opportunities from National Institutes of Health → National Institutes Of Health

Same awarding agency

Draft Policy Update to the NIH Policy for Data and Safety Monitoring

Solicitation # NOT-OD-27-006

The National Institutes of Health is proposing to update its 1998 Policy for Data and Safety Monitoring to expand its scope from clinical trials to all NIH-supported clinical research. This update introduces a risk-based approach to data and safety monitoring, requiring a monitoring plan tailored to the specific risks of each study to ensure participant safety and data integrity while reducing administrative burdens for lower-risk research. Key changes include removing the mandatory requirement for Data and Safety Monitoring Boards for all phase 3 or multi-site clinical trials, instead allowing for flexible, proportionate oversight approved by NIH Institutes, Centers, and Offices. Under the proposed policy, recipients and investigators must conduct risk assessments and implement approved monitoring plans prior to starting human subject activities. The policy defines roles for investigators, sponsors, and independent monitors, and establishes compliance mechanisms that may include funding termination for non-compliance. NIH is currently seeking public feedback on the draft policy and potential supplemental resources, such as templates and guidance tools, with comments accepted until January 6, 2027.

Other Management Consulting Services

POSTED

DEADLINE

USG Policy for the use of Super Intelligence

Solicitation # NOT-OD-27-011

The National Institutes of Health is implementing a policy transition mandated by Executive Order 14434, which requires the federal government to replace the terms Artificial Intelligence and AI with Super Intelligence and SI in all official documents, reports, websites, and public communications. This directive ensures standardized terminology across federal agencies to describe advanced machine-based systems. Under this policy, Super Intelligence is defined as a system capable of making predictions, recommendations, or decisions to influence real or virtual environments based on human-defined objectives. These systems are characterized by their ability to perceive environments, automate the creation of models through analysis, and use model inference to determine specific options for information or action.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

NIH Operates Under a Continuing Resolution

Solicitation # NOT-OD-26-131

The National Institutes of Health is operating under the Continuing Appropriations and Extensions Act, 2027, which extends government operations through December 11, 2026, at the Fiscal Year 2026 enacted level. Under this resolution, the NIH is prohibited from implementing revisions to the Uniform Administrative Requirements for Federal Awards until the expiration date. Additionally, NIH Institutes and Centers maintain the discretion to issue non-competing research grant awards at levels lower than those listed on the most recent Notice of Award, with potential upward adjustments considered only after FY 2027 appropriations are enacted. All legislative mandates and fiscal policies from FY 2026 remain in effect, including the salary limitation set at Executive Level II of the Federal Pay Scale. The Ruth L. Kirschstein National Research Service Award stipend levels and tuition fees also remain consistent with previous notices. Institutions are expected to monitor their expenditures closely during this period to ensure financial stability until new appropriations are finalized.

Administration of Public Health Programs

POSTED

about 1 month ago

DEADLINE

Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

Solicitation # RFA-OD-27-009

The National Institutes of Health is forecasting a limited competition to establish five new Research Evaluation and Commercialization Hubs (REACH). This program is designed to transition biomedical discoveries from academic settings into commercial products that enhance public health and patient care. Eligible colleges, universities, and nonprofit organizations will compete to create hubs that provide researchers with early-stage funding, technical resources, and mentorship in product development, regulatory navigation, and business management. These hubs will operate as a technology development consortium focused on high-priority technologies and the creation of prototypes and proof-of-concept studies. The program emphasizes public-private partnerships and non-federal matching funds to support federal priorities, including workforce development and the delivery of healthcare solutions to rural and underserved areas. While applications are not yet being solicited, this forecast allows potential applicants to establish the necessary collaborations for the upcoming peer-review process.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

IT Governance & Enterprise ArchitectureThe contract supports the National Institutes of Health in governing its IT systems, aligning strategic planning with federal mandates, and ensuring enterprise architecture integrity across its operations. It focuses on providing expert guidance to harmonize NIH’s technology initiatives with broader government standards, enhancing efficiency, compliance, and interoperability within the Department of Health and Human Services. The work will be performed primarily in Bethesda, Maryland, with the NAICS code 541611 indicating it is a professional, scientific, and technical services subcontract related to management consulting services. As a subcontract, this effort is embedded within a larger procurement structure and does not carry an advertised set-aside designation, meaning it is open to any qualified business entity capable of delivering the required capabilities. The opportunity was posted in June 2026 and is accessible through the SAM.gov portal for potential bidder consideration.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Tier 2 Help Desk & End-User SupportThe contract is for Tier 2 Help Desk and End-User Support services to be provided to staff of the National Institutes of Health under the Department of Health and Human Services. It requires comprehensive technical assistance covering hardware, software, and network issues, with responsibilities including ticket intake, prioritization, escalation, and final resolution. Services will be performed primarily at the Bethesda location with a ZIP code of 20892, ensuring on-site or closely coordinated support for NIH employees. This is a subcontract under NAICS code 541519, indicating it falls under other computer-related services, and was posted for opportunity on June 25, 2026. The contract does not specify a set-aside type or detailed point of contact, and all work must align with NIH’s internal support standards and escalation procedures.

Other Computer Related Services

POSTED

DEADLINE

Network Operations & SupportThe contract titled Network Operations & Support is a subcontract awarded by the National Institutes of Health under the U.S. Department of Health and Human Services to manage and sustain the NIH enterprise network infrastructure. The work encompasses continuous monitoring, troubleshooting, and performance optimization of critical network systems to ensure operational reliability and efficiency. The primary place of performance is in Bethesda, Maryland, with a zip code of 20892, indicating the physical location where services will be delivered. The contract falls under NAICS code 541513, which classifies it as Computer Systems Design and Related Services, emphasizing its technical and IT infrastructure focus. Although the solicitation number and point of contact are not provided, the posting date of June 25, 2026, suggests this is a future opportunity, and the contract is structured as a subcontract, meaning it is part of a larger prime contract arrangement. There is no set-aside designation specified, indicating it is open to all eligible contractors without preferential treatment based on business size or category.

Computer Facilities Management Services

POSTED

DEADLINE

Cybersecurity Operations & ComplianceThe contract titled Cybersecurity Operations & Compliance is a subcontract under the National Institutes of Health, part of the Department of Health and Human Services, aimed at delivering continuous cybersecurity monitoring, real-time threat detection, rapid incident response, and policy compliance services for NIH IT systems. The work is performance-based and requires the contractor to maintain robust, 24/7 operational capabilities to identify, analyze, and mitigate cyber threats across NIH infrastructure, ensuring alignment with federal security standards and regulatory requirements. The place of performance is designated as Bethesda, Maryland, with a zip code of 20892, indicating the primary location for service delivery, even though no specific office address or point of contact is provided. The contract is classified under NAICS code 541612, which corresponds to Computer Facilities Management Services, signaling that the focus is on managed cybersecurity operations rather than hardware or software procurement. It was posted on June 25, 2026, suggesting this is a future opportunity under solicitation, though no solicitation number is listed. As a subcontract, this effort supports a prime contractor or larger program, meaning the successful bidder will integrate their services into an existing cybersecurity framework. The absence of set-aside information implies the opportunity may be open to all eligible small or large businesses without specific socioeconomic preferences. The contractor must be prepared to operate at a high tempo, maintain strict compliance, and respond effectively to evolving cyber threats impacting critical health research systems.

Human Resources Consulting Services

POSTED

DEADLINE

Application Modernization & Software DevelopmentThe contract seeks to modernize legacy applications used by the National Institutes of Health through refactor, re-platform, or full rebuild efforts aligned with contemporary software development practices. The work will emphasize the integration of artificial intelligence and automation technologies to improve efficiency, scalability, and maintainability of critical health research systems. Performance is specifically required to occur in Bethesda, Maryland, with the North American Industry Classification System code 541511 indicating the focus on custom computer programming services. This subcontract opportunity is positioned under the Department of Health and Human Services and is intended to support NIH’s broader digital transformation goals by transitioning outdated systems to robust, future-ready platforms capable of handling evolving research and data needs.

Custom Computer Programming Services

POSTED

DEADLINE

Cloud Infrastructure Migration & ModernizationThe contract involves the migration and modernization of enterprise applications and data systems for the National Institutes of Health into secure cloud environments, requiring comprehensive architecture design, deployment, and seamless integration with existing infrastructure. The work focuses on enhancing security, scalability, and operational efficiency by transitioning legacy systems to modern cloud-based platforms, ensuring continuity and compliance with federal standards. The contract is classified as a subcontract under NAICS code 541512 for other computer related services, with performance located in Bethesda, Maryland, 20892. It was posted on June 25, 2026, and is part of the Department of Health and Human Services initiative to advance NIH's digital capabilities. There is no specified set-aside type, and the point of contact information is not provided, though the work is central to modernizing critical health research systems within a highly regulated environment.

Computer Systems Design Services

POSTED

DEADLINE

Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria – A Model for Mosquito-Borne Diseases

Solicitation # RFA-AI-28-024

The National Institutes of Health, through the National Institute of Allergy and Infectious Diseases, is forecasting an opportunity to fund basic research, discovery, and preclinical development of highly effective vaccines for malaria and other mosquito-borne illnesses. The program emphasizes the use of novel vaccine design strategies, specifically focusing on structure-based immunogen design and combination vaccines intended to lower parasite infection rates and reduce the overall disease burden. This initiative is categorized under NAICS code 541715 and is managed by the Department of Health and Human Services. Interested parties can contact the Malaria and Other Mosquito Borne Diseases office for further information regarding this forecast, which aims to leverage recent technological innovations to advance next-generation vaccine development.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Procurement of Service Support of Rees Scientific Electronic Temperature Monitoring System in DLM

Solicitation # NOI-CC-26-003181

The National Institutes of Health intends to award a sole-source, severable firm-fixed-price contract to Rees Scientific USA for service support, validation, and calibration of the Electronic Temperature Monitoring System within the Department of Laboratory Medicine in Bethesda, Maryland. With an estimated value of 21,593.43 dollars, the contract covers a twelve-month base period from April 24, 2026, through April 23, 2027. The procurement is justified under FAR 6.302-1 and 41 U.S.C. 253(c)(1) as Rees Scientific is identified as the only responsible source capable of meeting specific technical requirements, including ISO 9001:2015 certification, ISO 17025 accreditation, and the ability to support a hybrid configuration of hardwired, wireless, and Wi-Fi sensors. The scope of work includes the annual qualification and calibration of sensors for temperature, humidity, CO2, and differential pressure using NIST traceable instruments to ensure compliance with CAP, cGMP, and 21CFR requirements. Key deliverables involve executing Design, Installation, Operational, and Performance Qualifications, providing durable certification labels for all monitored equipment, and implementing system security upgrades such as TLS 1.2 encrypted SQL database connections. The system must be fully Windows-based, supporting up to 128 sensors per node with eight levels of user access permissions. All services must be performed by trained Rees technicians who meet the necessary education and certification standards for a clinical laboratory environment.

All Other Miscellaneous General Purpose Machinery Manufacturing

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS